Latest Posts
-
Why the Jobs Argument Is Hurting Pharma
Anyone advocating for better conditions for the pharmaceutical industry—whether trade associations, company representatives, investors, or politicians—eventually reaches for the same argument: “Hundreds of thousands of jobs depend directly and indirectly on this industry.” And therefore, the argument goes, policymakers cannot ignore it. They can. And they should. Not because the numbers are wrong. They may…
-
CEO Espresso highlights from 2025: Strategy
What distinguishes a strategy on paper from one that is actually lived? We asked CEOs from very different contexts exactly that. Their answers varied, but they all revolved around one theme: consequence. 🔹 Gunnar Pahnke, CEO of Azerfon: “Execution is directly linked to the bonus payments of all CXOs — over a three-year period. A…
-
Entrepreneurship
Last night at Pitch & Pretzels, hosted at KPMG’s offices in Cologne, the focus was naturally on ideas. What problem does the startup want to solve?What market is it addressing? How big could this become?How convincing is the team?And, of course: how do idea, capital, and execution come together? But another question stayed with me:…